VA
MDT icon

VestGen Advisors’s Medtronic MDT Stock Holding History

VestGen Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$694K Sell
8,872
-1,399
-14% -$113K 0.02% 561
2026
Q1 		$789K Sell
10,271
-6,300
-38% -$604K 0.02% 520
2025
Q4 		$1.59M Sell
16,571
-2,586
-13% -$251K 0.07% 268
2025
Q3 		$1.82M Buy
19,157
+15,924
+493% +$1.46M 0.06% 264
2025
Q2 		$282K Buy
3,233
+589
+22% +$50K 0.01% 512
2025
Q1 		$238K Buy
+2,644
New +$237K 0.01% 508

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

VestGen Advisors's MDT Position: Q2 2026 in Review

VestGen Advisors reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $113K and leaving 8,872 shares worth $694K. The position accounts for 0.02% of the portfolio, ranked #561.

VestGen Advisors first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.82M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • VestGen Advisors held 8,872 shares of Medtronic worth $694K as of Q2 2026.
  • VestGen Advisors sold 1,399 Medtronic shares in Q2 2026, an estimated $113K.
  • Medtronic made up 0.02% of VestGen Advisors's portfolio in Q2 2026, its #561 holding.
  • VestGen Advisors first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • VestGen Advisors's Medtronic position peaked at $1.82M in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.